FDA product code MXA: System, Test, Breath Nitric Oxide
MXA is the FDA product code for system, test, breath nitric oxide. It is a Class II device, regulated under 21 CFR 862.3080 and reviewed by the Clinical Chemistry panel. FDA has cleared 14 510(k) submissions under MXA, 4 in the last five years, from 8 different applicants. The average 510(k) review took 190 days (median 147); 156 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 1 recall for MXA devices.
Classification
| Field | Value |
|---|---|
| Device name | System, Test, Breath Nitric Oxide |
| Device class | Class II |
| Regulation | 21 CFR 862.3080 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Toxicology |
| Premarket route | 510(k) |
510(k) clearances per year for MXA
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 233 |
| 2019 | 1 | 124 |
| 2021 | 1 | 364 |
| 2023 | 1 | 569 |
| 2024 | 1 | 90 |
| 2025 | 2 | 222 |
Compare with all 510(k) review times · Search every MXA clearance
Top MXA applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Aerocrine AB | 5 | 2015-02-26 |
| Bosch Healthcare Solutions GmbH | 2 | 2025-09-11 |
| Apieron, Inc. | 2 | 2009-01-27 |
| Mgc Diagnostics Corporation | 1 | 2025-11-26 |
| Caire Diagnostics, Inc. | 1 | 2023-06-07 |
3 more applicants have MXA clearances. See the full list in Caduvo.
Most recent MXA clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K251674 | Mgc Diagnostics Corporation | Fenom Flo FeNO Monitoring System | 2025-11-26 | 180 |
| K243926 | Bosch Healthcare Solutions GmbH | Vivatmo pro-S | 2025-09-11 | 265 |
| K233775 | Bosch Healthcare Solutions GmbH | Vivatmo pro | 2024-02-22 | 90 |
| K213611 | Caire Diagnostics, Inc. | Fenom Pro | 2023-06-07 | 569 |
| K203695 | Bedfont Scientific, Ltd. | NObreath® | 2021-12-17 | 364 |
Recalls for MXA devices
1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2021-02-26.
| Year | Recalls |
|---|---|
| 2021 | 1 |
Frequently asked questions
What is FDA product code MXA?
MXA is the FDA product code for system, test, breath nitric oxide. It is a Class II device, regulated under 21 CFR 862.3080 and reviewed by the Clinical Chemistry panel.
What device class is MXA?
Class II, regulation 21 CFR 862.3080. Typical premarket route: 510(k).
How long does a 510(k) take for product code MXA?
Across 14 cleared submissions the average was 190 days from receipt to decision (median 147).
Which companies have the most MXA clearances?
Aerocrine AB (5); Bosch Healthcare Solutions GmbH (2); Apieron, Inc. (2); Mgc Diagnostics Corporation (1); Caire Diagnostics, Inc. (1).
Have MXA devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2021-02-26.
Next steps
- Run an FDA pathway report with predicate devices for product code MXA
- Run a recall and safety report across every MXA manufacturer
- Watch product code MXA for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times